1. Home
  2. VERU vs THCH Comparison

VERU vs THCH Comparison

Compare VERU & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

SELL

Current Price

$3.06

Market Cap

48.2M

Sector

Health Care

ML Signal

SELL

Logo TH International Limited Ordinary shares

THCH

TH International Limited Ordinary shares

N/A

Current Price

$1.60

Market Cap

57.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VERU
THCH
Founded
1971
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
57.5M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VERU
THCH
Price
$3.06
$1.60
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
5.5M
5.9K
Earning Date
05-12-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,296,958.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$1.60
52 Week High
$7.33
$3.25

Technical Indicators

Market Signals
Indicator
VERU
THCH
Relative Strength Index (RSI) 55.43 37.60
Support Level $2.15 N/A
Resistance Level $3.68 $2.27
Average True Range (ATR) 0.67 0.12
MACD -0.02 -0.01
Stochastic Oscillator 18.01 10.50

Price Performance

Historical Comparison
VERU
THCH

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About THCH TH International Limited Ordinary shares

TH International Ltd is the exclusive master franchisee in China for Tim Hortons, a world-wide coffee and bakery shop brand. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under a single reportable segment, Tim Hortons. The company's revenue is derived from sales of food, beverages, and packaged products by company-owned and operated stores, franchise fees, and revenue from other franchise support activities. Its geographic revenue is derived from operations in the PRC.

Share on Social Networks: